Enovis (ENOV) vs Lucid Diagnostics (LUCD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Enovis (ENOV) has outperformed Lucid Diagnostics (LUCD) over the past year, losing 45.2% versus a loss of 46.7%. Over five years, ENOV leads with a -80.0% price change compared with -93.0% for LUCD. Enovis is the larger company by market cap ($1.02 billion vs $121.0 million), about 8.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ENOV | LUCD |
|---|---|---|
| Share price | $17.70 | $0.6336 |
| Market cap | $1.02B | $120.99M |
| 1-day change | +1.52% | -2.54% |
| YTD return | -34.57% | -40.36% |
| 1-year return | -45.15% | -46.71% |
| 5-year return | -79.99% | -93.05% |
| Forward P/E | 4.93 | — |
| EPS (TTM) | $-19.23 | $-0.44 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $34.28 | $1.63 |
| 52-week low | $16.70 | $0.50 |
| Distance from 52-week high | -48.38% | -61.10% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +112.38% | +531.31% |
| Average volume | 1.46M | 1.35M |
| Shares outstanding | 57.67M | 190.95M |
| Employees | 7,802 | 82 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Enovis is about 8.4 times larger than Lucid Diagnostics by market value ($1.02B vs $120.99M).
About Enovis
ENOV stock →Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments.
Health Care · Industrial Specialties · 7,802 employees
About Lucid Diagnostics
LUCD stock →Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States.
Health Care · Medical/Dental Instruments · 82 employees
ENOV vs LUCD FAQ
Which is bigger, Enovis or Lucid Diagnostics?
Enovis (ENOV) is larger, with a market capitalization of $1.02B compared with $120.99M for Lucid Diagnostics (LUCD).
Which stock has performed better over the past year, ENOV or LUCD?
ENOV returned -45.15% over the past 12 months, compared with -46.71% for LUCD (price return, excluding dividends). Past performance does not predict future results.
Are Enovis and Lucid Diagnostics in the same industry?
Both are in the Health Care sector, but in different industries: Industrial Specialties for Enovis and Medical/Dental Instruments for Lucid Diagnostics.